UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 4, 2014
Accretive Health, Inc.
(Exact Name of Registrant as Specified in Charter)
Delaware | 001-34746 | 02-0698101 | ||
(State or Other Juris- diction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||
401 North Michigan Avenue, Suite 2700, Chicago, Illinois | 60611 | |
(Address of Principal Executive Offices) | (Zip Code) | |
Registrant's telephone number, including area code: (312) 324-7820
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |
Item 5.02 Departure of Directors or Certain Officer; Election of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers
On February 4, 2014, Miles McHugh, Senior Vice President, Chief Accounting Officer, of the Company notified the Company that he has decided not to accept the Company’s offer to relocate him and his family to Dallas, Texas in connection with the restructuring plan described in Item 2.05 of the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on January 24, 2014, and therefore he will leave the Company, effective September 30, 2014 (the “Departure Date”). Mr. McHugh will continue to perform his duties until the Departure Date.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ACCRETIVE HEALTH, INC. | ||||||
Date: February 10, 2014 | By: | /s/ Sean F. Orr | ||||
Sean F. Orr | ||||||
Chief Financial Officer and Treasurer | ||||||